Analyst Price Targets — MEDP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 24, 2026 1:23 pm | Ryan Halsted | RBC Capital | $692.00 | $601.73 | TheFly | Medpace price target raised to $692 from $484 at RBC Capital |
| July 24, 2026 11:55 am | — | Mizuho Securities | $665.00 | $605.82 | TheFly | Medpace price target raised to $665 from $586 at Mizuho |
| July 24, 2026 11:51 am | — | BMO Capital | $600.00 | $605.82 | TheFly | Medpace price target raised to $600 from $400 at BMO Capital |
| July 24, 2026 11:18 am | — | Robert W. Baird | $624.00 | $605.82 | TheFly | Medpace price target raised to $624 from $547 at Baird |
| July 23, 2026 7:36 pm | Luke Sergott | Barclays | $600.00 | $605.82 | TheFly | Medpace price target raised to $600 from $450 at Barclays |
| July 23, 2026 7:35 pm | — | Leerink Partners | $620.00 | $605.82 | TheFly | Medpace price target raised to $620 from $515 at Leerink |
| July 23, 2026 1:33 pm | — | Deutsche Bank | $535.00 | $603.00 | TheFly | Medpace price target raised to $535 from $480 at Deutsche Bank |
| July 13, 2026 11:43 am | — | Mizuho Securities | $586.00 | $538.23 | TheFly | Medpace price target raised to $586 from $495 at Mizuho |
| July 8, 2026 9:28 am | Eric Coldwell | Robert W. Baird | $547.00 | $546.29 | TheFly | Medpace downgraded to Neutral from Outperform at Baird |
| July 7, 2026 7:34 am | David Windley | Jefferies | $515.00 | $565.09 | StreetInsider | Jefferies Downgrades Medpace (MEDP) to Hold |
Latest News for MEDP
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
American Capital Management Inc. bought a new stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 210,217 shares of the company's stock, valued at approximately $111,329,000. Medpace makes up about 5.0%
Medpace stock is back below a buy point of 628.92. The medical research contractor delivered an earnings beat for its second quarter.
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
The CEO sold 15,978 shares at a weighted-average price of $623.93 over two trading days ending Aug. 24, 2026. The transaction involved shares equal to 3% of Troendle's direct equity holdings and 0.3% of his total combined stake.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MEDP.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.